Literature DB >> 21243502

Ovarian morphology and endocrine function in polycystic ovary syndrome.

Gilberto Tena1, Carlos Moran, Rocio Romero, Segundo Moran.   

Abstract

PURPOSE: To assess the relationship between ovarian morphology, hormonal levels and anthropometrical characteristics in a group of patients with polycystic ovary syndrome (PCOS).
METHODS: This prospective, cross-sectional study included 82 patients with diagnosis of PCOS and 21 women with regular menstrual cycles without hyperandrogenism. They were submitted to endovaginal pelvic ultrasound. Anthropometric measures and hormonal levels of LH, FSH, insulin, total testosterone (T), free T, dehydroepiandrosterone and dehydroepiandrosterone sulfate were evaluated. The morphology of polycystic ovary (PCO) was considered when 12 or more follicles, less than 10 mm in diameter, in one or both ovaries, were observed. PCOS patients were divided into two groups: with PCO (n = 51) and without PCO (n = 31).
RESULTS: In 51 out of 82 (62%) patients with PCOS, an image of PCO was observed. PCOS Patients with PCO showed a significantly greater body mass index and hip perimeter than PCOS patients without PCO. Higher levels of total T and free T were found in PCOS patients with PCO compared to those without PCO.
CONCLUSION: PCOS patients with PCO on ultrasound present greater hyperandrogenism and obesity than PCOS patients without PCO. The presence of PCO appears to indicate a major clinical alteration of PCOS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21243502     DOI: 10.1007/s00404-010-1816-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  10 in total

1.  Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome.

Authors:  Yanyuan Zhou; Huan Lan; Zhewen Dong; Wanying Li; Bo Qian; Zhen Zeng; Wen He; Jia-Le Song
Journal:  Oxid Med Cell Longev       Date:  2022-05-26       Impact factor: 7.310

2.  Obesity differentially affects phenotypes of polycystic ovary syndrome.

Authors:  Carlos Moran; Monica Arriaga; Gustavo Rodriguez; Segundo Moran
Journal:  Int J Endocrinol       Date:  2012-07-08       Impact factor: 3.257

3.  Hormonal and metabolic effects of polyunsaturated fatty acid (omega-3) on polycystic ovary syndrome induced rats under diet.

Authors:  Elaheh Ouladsahebmadarek; Arash Khaki; Sharareh Khanahmadi; Hamidreza Ahmadi Ashtiani; Pooya Paknejad; Mohammad Reza Ayubi
Journal:  Iran J Basic Med Sci       Date:  2014-02       Impact factor: 2.699

4.  Correlations Between Anthropometry and Lipid Profile in Women With PCOS.

Authors:  Donthu Kiranmayee; Kothapalli Kavya; Yalamanchali Himabindu; Manne Sriharibabu; Gadi Leela Jaya Madhuri; Swargam Venu
Journal:  J Hum Reprod Sci       Date:  2017 Jul-Sep

5.  Antioxidant effect of genistein on ovarian tissue morphology, oxidant and antioxidant activity in rats with induced polycystic ovary syndrome.

Authors:  Samira Rajaei; Alireza Alihemmati Ph D; Ali Abedelahi Ph D
Journal:  Int J Reprod Biomed       Date:  2019-03-03

6.  Polycystic ovarian morphology is associated with primary dysmenorrhea in young Korean women.

Authors:  Jee Young Jeong; Min Kyoung Kim; Inha Lee; Jisun Yun; Young Bin Won; Bo Hyon Yun; Seok Kyo Seo; SiHyun Cho; Young Sik Choi; Byung Seok Lee
Journal:  Obstet Gynecol Sci       Date:  2019-07-22

7.  DHEA and polycystic ovarian syndrome: Meta-analysis of case-control studies.

Authors:  Jiby Jolly Benjamin; MaheshKumar K; Teena Koshy; Maruthy K N; Padmavathi R
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

8.  Genistein Blunted Detrimental Effects of Polycystic Ovary Syndrome on the Ovarian Tissue of Rats by Improving Follicular Development and Gonadotropin Secretion.

Authors:  Samran Khezri; Alireza Alihemmati; Ali Abedelahi
Journal:  JBRA Assist Reprod       Date:  2022-08-04

9.  The Relationship between Ovarian Ultrasound Parameters and Endocrine and Metabolic Indicators in Patients with Ovarian Syndrome.

Authors:  Changqing Sheng; Jin Zhang; Jiang Jue
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-30       Impact factor: 2.650

10.  Dehydroepiandrosterone-Sulfate, Insulin Resistance and Ovarian Volume Estimation in Patients With Polycystic Ovarian Syndrome.

Authors:  Chrysi Christodoulaki; Eftihios Trakakis; Vasilios Pergialiotis; Periklis Panagopoulos; Charalampos Chrelias; Dimitrios Kassanos; Dimos Sioutis; Nikolaos Papantoniou; Dimitrios Xirofotos
Journal:  J Family Reprod Health       Date:  2017-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.